Erythromycin Delayed-Release Tablets 333mg from China
Enteric-coated delayed-release tablets containing 333mg of erythromycin base to protect gastric mucosa, for duodenal ulcer treatment in retail bottles. This formulated antibiotic dosage form, regardless of release mechanism, is put up in measured doses for retail sale, classifying under tariff item 3004.20.00.
Duty Rate — China → Canada
0%
Import Tips
• Confirm the product has a valid Drug Identification Number (DIN) from Health Canada
• Ensure the enteric coating does not affect the product's classification as an antibiotic medicament
• Keep the product's formulation details available for CBSA verification